Molecular Partners AG: Form 20-F for the period ended Dec 31, 2022
Filed with the SEC on Mar 9, 2023 and accepted by EDGAR at Mar 9, 2023, 16:01 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-01-01 to 2022-12-31 | CHF 189.6m | ifrs-full:Revenue |
| Operating income | 12 months2022-01-01 to 2022-12-31 | CHF 116.6m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months2022-01-01 to 2022-12-31 | CHF 0 | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months2022-01-01 to 2022-12-31 | CHF 117.9m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months2022-01-01 to 2022-12-31 | CHF 3.54 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months2022-01-01 to 2022-12-31 | CHF 3.63 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months2022-01-01 to 2022-12-31 | CHF 118.6m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months2022-01-01 to 2022-12-31 | CHF 1.2m | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | At period end2022-12-31 | CHF 87.9m | ifrs-full:CashAndCashEquivalents |
| Current assets | At period end2022-12-31 | CHF 254.8m | ifrs-full:CurrentAssets |
| Total assets | At period end2022-12-31 | CHF 262.3m | ifrs-full:Assets |
| Current liabilities | At period end2022-12-31 | CHF 17.3m | ifrs-full:CurrentLiabilities |
| Total liabilities | At period end2022-12-31 | CHF 27.1m | ifrs-full:Liabilities |
| Shareholders' equity | At period end2022-12-31 | CHF 235.2m | ifrs-full:Equity |
| Shares outstanding | At period end2022-12-31 | 36,044,706 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001745114-23-000003. Last ingested by Listed: Oct 29, 2026, 06:05 ET. Listed shows no prices and gives no investment advice.